Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.36
+0.02 (0.37%)
At close: Apr 28, 2026, 4:00 PM EDT
5.38
+0.02 (0.41%)
Pre-market: Apr 29, 2026, 8:59 AM EDT
Abeona Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 78.44 | 23.36 | 14.47 | 14.22 | 32.94 | Upgrade
|
| Short-Term Investments | 112.97 | 74.36 | 37.75 | 37.93 | 12.09 | Upgrade
|
| Cash & Short-Term Investments | 191.4 | 97.72 | 52.23 | 52.15 | 45.02 | Upgrade
|
| Cash Growth | 95.87% | 87.11% | 0.15% | 15.82% | -52.62% | Upgrade
|
| Accounts Receivable | 6.15 | - | - | - | 3 | Upgrade
|
| Other Receivables | 0.57 | 1.65 | 2.44 | 0.19 | - | Upgrade
|
| Receivables | 6.72 | 1.65 | 2.44 | 0.19 | 3 | Upgrade
|
| Inventory | 5.49 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 1.29 | 1.14 | 0.73 | 0.42 | 2.38 | Upgrade
|
| Restricted Cash | - | 0.34 | 0.34 | 0.34 | 5.89 | Upgrade
|
| Total Current Assets | 204.91 | 100.85 | 55.74 | 53.1 | 56.29 | Upgrade
|
| Property, Plant & Equipment | 13.88 | 7.98 | 7.99 | 11.07 | 21.74 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 1.38 | Upgrade
|
| Other Long-Term Assets | 0.78 | 0.1 | 0.28 | 0.04 | 0.17 | Upgrade
|
| Total Assets | 219.57 | 108.93 | 64 | 64.21 | 79.59 | Upgrade
|
| Accounts Payable | 7.89 | 3.44 | 1.86 | 1.81 | 4.33 | Upgrade
|
| Accrued Expenses | 8.47 | 6.33 | 5.99 | 3.99 | 5.59 | Upgrade
|
| Current Portion of Long-Term Debt | 12.22 | 5.93 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.86 | 0.82 | 1 | 1.77 | 1.82 | Upgrade
|
| Current Income Taxes Payable | 0.13 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 0 | 0.06 | 4.58 | 0.2 | 4.9 | Upgrade
|
| Total Current Liabilities | 29.57 | 16.59 | 13.42 | 7.78 | 16.62 | Upgrade
|
| Long-Term Debt | 7.81 | 13.04 | - | - | - | Upgrade
|
| Long-Term Leases | 4.07 | 3.26 | 4.4 | 5.85 | 7.56 | Upgrade
|
| Other Long-Term Liabilities | 18.9 | 32.01 | 31.35 | 23.82 | 13.04 | Upgrade
|
| Total Liabilities | 60.35 | 64.9 | 49.18 | 37.45 | 37.22 | Upgrade
|
| Common Stock | 0.55 | 0.46 | 0.27 | 0.18 | 1.47 | Upgrade
|
| Additional Paid-In Capital | 900.6 | 856.82 | 764.15 | 722.05 | 696.56 | Upgrade
|
| Retained Earnings | -742.08 | -813.26 | -749.52 | -695.34 | -655.64 | Upgrade
|
| Comprehensive Income & Other | 0.14 | 0.01 | -0.07 | -0.13 | -0.03 | Upgrade
|
| Shareholders' Equity | 159.22 | 44.03 | 14.83 | 26.76 | 42.37 | Upgrade
|
| Total Liabilities & Equity | 219.57 | 108.93 | 64 | 64.21 | 79.59 | Upgrade
|
| Total Debt | 24.97 | 23.05 | 5.4 | 7.63 | 9.38 | Upgrade
|
| Net Cash (Debt) | 166.44 | 74.67 | 46.83 | 44.52 | 35.65 | Upgrade
|
| Net Cash Growth | 122.89% | 59.47% | 5.17% | 24.90% | -58.70% | Upgrade
|
| Net Cash Per Share | 2.52 | 1.82 | 2.19 | 5.66 | 9.05 | Upgrade
|
| Filing Date Shares Outstanding | 57.05 | 48.53 | 27.36 | 17.71 | 5.9 | Upgrade
|
| Total Common Shares Outstanding | 55.04 | 45.64 | 26.52 | 17.72 | 5.89 | Upgrade
|
| Working Capital | 175.34 | 84.27 | 42.32 | 45.32 | 39.67 | Upgrade
|
| Book Value Per Share | 2.89 | 0.96 | 0.56 | 1.51 | 7.20 | Upgrade
|
| Tangible Book Value | 159.22 | 44.03 | 14.83 | 26.76 | 40.98 | Upgrade
|
| Tangible Book Value Per Share | 2.89 | 0.96 | 0.56 | 1.51 | 6.96 | Upgrade
|
| Machinery | 12.02 | 9.98 | 7.92 | 9.02 | 10.98 | Upgrade
|
| Construction In Progress | - | 0.62 | - | - | 3.22 | Upgrade
|
| Leasehold Improvements | 15.12 | 8.81 | 8.6 | 8.61 | 8.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.